Bristol-Myers Squibb declares quarterly dividend
22 December 2008 00:00 in Pharmaceutical Company Financials
Bristol-Myers Squibb has announced its quarterly dividend.
The company's board of directors announced the amount to be $0.31 (0.21 pounds) per share on the $.10 par value common stock of the organisation.
Set to be payable to stockholders on February 2nd next year, the transaction follows the close of business on January 2nd 2009.
The board also declared a quarterly dividend of $0.50 per share on the $2 convertible preferred stock of the company.
Payable on March 2nd to stockholders of record, it follows the close of business on February 6th.
The board said it expected dividend for the full year of 2009 of $1.24 per share on the $0.10 par value common stock, subject to the quarterly review.
Last week, Bristol-Myers Squibb announced new data from phase III breast cancer studies.
The research of the drug Ixempra plus capecitabine sought its efficacy and safety, in comparison to capecitabine on its own.
It involved 2,000 patients and those on the amalgamation therapy had an overall response rate of 31 per cent, in contrast to 15 per cent.
Bristol-Myers Squibb added the progression free survival of the combination group was a median of 4.2 months, compared to 1.7 months for the singular drug-treated group.
Other news stories from 22/12/2008
Read more in the Zenopa News Archive
How this news is generated
Story collated for Zenopa by the Adfero News Agency